The landscape of dementia diagnosis has progressed radically with the arrival of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-based assessments that could detect Alzheimer's pathology many years right before signs or symptoms emerge. Though these technological advancements signify extraordinary progress in understanding neurodegenerative disorders, they've not https://epicurusu752pyh1.blognody.com/profile